Oct 20, 2026 07:50AM
Oct 18, 2026 06:05PM
Oct 9, 2026 06:45AM
Oct 9, 2026 06:45AM
Oct 6, 2026 09:06AM
Oct 5, 2026 07:50AM
Oct 5, 2026 07:50AM Lilly to present new data across its dermatology portfolio with 21 presentations at Fall Clinical 2026, in pursuit of advancing care for chronic skin conditions
Oct 2, 2026 03:06PM
Oct 2, 2026 03:05PM
Oct 1, 2026 07:01AM
Oct 1, 2026 07:00AM
Sep 30, 2026 06:05PM
Sep 30, 2026 06:00PM
Sep 30, 2026 10:22AM 3 Biotech Stocks Throwing Their Weight Around, and Another that Wants to Help You Lose Yours
Sep 30, 2026 10:15AM
Sep 30, 2026 10:15AM
Sep 30, 2026 08:05AM
Sep 30, 2026 08:03AM
Sep 29, 2026 06:00PM
Sep 29, 2026 07:01AM
Sep 29, 2026 07:00AM Lilly's Zepbound (tirzepatide 10 mg and 15 mg) was associated with more weight loss than Wegovy HD (semaglutide injection 7.2 mg) in a new indirect treatment comparison
Sep 29, 2026 06:03AM
Sep 29, 2026 03:00AM
Sep 28, 2026 06:45AM
Sep 28, 2026 06:45AM
Sep 25, 2026 05:12PM
Sep 25, 2026 05:11PM
Sep 24, 2026 06:46AM FDA approves Lilly's once-weekly basal insulin for type 2 diabetes
Sep 24, 2026 06:45AM
Sep 21, 2026 05:50PM
Sep 21, 2026 05:40PM
Sep 18, 2026 01:54PM
Sep 18, 2026 01:54PM
Sep 15, 2026 06:45AM
Sep 15, 2026 06:45AM Lilly to present new data on Foundayo, retatrutide, and eloraTZP at EASD 2026, as it strives to change the course of cardiometabolic health
Aug 31, 2026 07:01AM
Aug 31, 2026 07:00AM
Aug 28, 2026 07:00AM
Aug 28, 2026 07:00AM
Aug 26, 2026 06:45AM
Aug 26, 2026 06:45AM
Aug 18, 2026 12:57PM A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.
Aug 12, 2026 09:15AM
Aug 12, 2026 05:57AM
Aug 12, 2026 05:30AM
Aug 5, 2026 06:45AM
Aug 3, 2026 07:45AM
Aug 3, 2026 07:45AM
Jul 23, 2026 06:45AM Lilly's retatrutide meets goals in two Phase 3 obesity trials
Jul 23, 2026 06:45AM

334,541 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All